A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. TG Therapeutics Inc’s current trading price is -57.25% away from its 52-week high, while its distance from the 52-week low is 136.07%. The stock’s price range for this time frame has been between $6.46 and $35.67. The trading volume of the company’s shares in the Healthcare reached around 2.15 million for the day, which was evidently lower than the average daily volume of 4.89 million over the last three months.
The stock market performance of TG Therapeutics Inc has been very steady. Over the last year, the company’s stock hit its highest at $35.67 on 05/04/23, while the lowest price during the same time frame was $6.46, recorded on 10/16/23.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
How Financial Performance Impacts Market Capitalization
TG Therapeutics Inc (TGTX) has experienced a quarterly decline of -18.93% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.35B and boasts a workforce of 264 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 14.89, with a change in price of +8.05. Similarly, TG Therapeutics Inc recorded 5,588,103 in trading volume during the last 100 days, posting a change of +111.81%.
How TGTX’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for TGTX stands at 0.69. Similarly, the long-term debt-to-equity ratio is also 0.68.
TGTX Stock Stochastic Average
TG Therapeutics Inc’s raw stochastic average for the past 50 days is currently at 24.52%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 37.39%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 39.36% and 38.79%, respectively.
TGTX Stock Price Performance Analysis
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Until today this year the stock’s price performance recorded a decrease of -10.71%. However, over the last six months, the performance has been weaker by 63.98%. The price of TGTX increased 17.13% over the last 30 days. And in the last five days, it has fallen by -0.72%.
